BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
What was lobbied
18 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Biomass Crop Assistance Program (BCAP) Funding H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 H.J. RES.48: Department of Defense and Continuing Appropriations Act for FY 2011 H.R. 1/H.J. RES.92: Continuing Appropriations Act for FY 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 1/H.J. RES 92: Continuing Appropriations Act for FY 2011 H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Funding for Bio-based Products H.R. 2354: The Energy and Water Appropriations Act for FY 2012 Funding for Biofuels H.R. 2354: The Energy and Water Appropriations Act for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Genetically Engineered (GE) Animals H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE Salmon
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| AB BASU New | — |
| MATT CARR | — |
| SARAH THORNTON CASWELL New | — |
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
Fuel/Gas/Oil FUE
Renewable Fuels Standard Regulatory Oversight Implementation of Energy Independence and Security Act of 2007 Biofuels Next Generation Incentives: Farm Bill Reauthorization Economic Growth Impact/Potential of Advanced Biofuels Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Funding for Biofuels H.R. 2354: The Energy and Water Appropriations Act for FY 2012 Investment Tax Credit Options Biofuels Production Tax Credit Extension Domestic Manufacturing and Energy Jobs Act (Discussion Draft) Biofuels Production Tax Credit Modification for Algae-based Biofuels DOE Loan Guarantees and Grants under the Energy Policy Act of 2005 (Implementation and Funding) Climate Change Benefits Tax Credit Bio-based Products Expansion of DOE and USDA Loan Guarantee Programs Tax Credit Next Generation Incentives: Farm Bill Reauthorization Funding for Bio-based Products H.R. 2354: The Energy and Water Appropriations Act for FY 2012 USDA BioPreferred Program Renewable Chemicals Farm Bill Reauthorization: DOE Loan Guarantees S.847: The Safe Chemicals Act of 2011 (TSCA Reform Proposals) New Production Tax Credit/Revisions to Existing Tax Credits
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT CARR | — |
| SARAH THORNTON CASWELL New | — |
| BRENT ALAN DELMONTE | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW SCHUMAKER | — |
| RINA SINGH New | — |
Homeland Security HOM
Biodefense Research, Development and Procurement HHS Countermeasures Review Pandemic and All-Hazards Preparedness Act Reauthorization Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 H.J. RES.48: Department of Defense and Further Additional Continuing Appropriations Act for FY 2011 H.R. 1/H.J. RES.92: Continuing Appropriations Act for FY 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
Medicare/Medicaid MMM
Reimbursement for Innovative Products Medicare Policies and Regulation Medicare Prescription Drug Coverage Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Medicaid Rebates Dual Eligibles Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Independent Payment Advisory Board Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Repeal
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| SANDRA DENNIS | — |
| JEANNE HAGGERTY | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| LAUREL TODD | — |
| ANNA KATHERINE WEINSTEIN | — |
Consumer Issues/Safety/Products CSP
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning USDA/APHIS Agricultural Biotechnology Regulations Efficient Science-Based Review of Biotech Products National Environmental Policy Act Requirements Coexistence of Production Systems Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE Salmon FDA Approval Labeling Labeling of Genetically Engineered Crops U.S. Government Policy Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 1/H.J. RES 92: Continuing Appropriations Act for FY 2011 H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| AB BASU New | — |
| BRENT ALAN DELMONTE | — |
| SANDRA DENNIS | — |
| DAVID EDWARDS | — |
| ANDREW EMMETT | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
Energy/Nuclear ENG
Renewable Fuels Standard Regulatory Oversight Implementation of Energy Independence and Security Act of 2007 Biofuels Next Generation Incentives: Farm Bill Reauthorization Economic Growth Impact/Potential of Advanced Biofuels Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Funding for Biofuels H.R. 2354: The Energy and Water Appropriations Act for FY 2012 Investment Tax Credit Options Biofuels Production Tax Credit Extension Domestic Manufacturing and Energy Jobs Act (Discussion Draft) Biofuels Production Tax Credit Modification for Algae-based Biofuels DOE Loan Guarantees and Grants under the Energy Policy Act of 2005 (Implementation and Funding) Climate Change Benefits Tax Credit Bio-based Products Expansion of DOE and USDA Loan Guarantee Programs Tax Credit Next Generation Incentives: Farm Bill Reauthorization Funding for Bio-based Products H.R. 2354: The Energy and Water Appropriations Act for FY 2012 USDA BioPreferred Program Renewable Chemicals Farm Bill Reauthorization: DOE Loan Guarantees S.847: The Safe Chemicals Act of 2011 (TSCA Reform Proposals) New Production Tax Credit/Revisions to Existing Tax Credits
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT CARR | — |
| SARAH THORNTON CASWELL New | — |
| BRENT ALAN DELMONTE | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW SCHUMAKER | — |
| RINA SINGH New | — |
Food Industry (safety, labeling, etc.) FOO
Labeling of Genetically Engineered Crops U.S. Government Policy Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE Salmon FDA Approval Labeling
| Lobbyist | Covered position, as disclosed |
|---|---|
| AB BASU New | — |
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
Animals ANI
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE salmon FDA Approval Labeling
| Lobbyist | Covered position, as disclosed |
|---|---|
| AB BASU New | — |
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
Pharmacy PHA
Medicare Prescription Drug Coverage Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Medicaid Rebates Dual Eligibles Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| SANDRA DENNIS | — |
| ANDREW EMMETT | — |
| JEANNE HAGGERTY | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
Science/Technology SCI
Research & Development Tax Credit Extension H.R. 942: American Research and Competitiveness Act of 2011 Small Business Innovation and Research (SBIR) Program Reauthorization S.493: SBIR/STTR Reauthorization Act of 2011 HR 1425: Creating Jobs Through Small Business Innovation Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| ALAN EISENBERG | — |
| ELIZABETH CARTIER ESHAM | — |
| MATTHEW SCHUMAKER | — |
Clean Air and Water (quality) CAW
Biofuels Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Climate Change Benefits Regulatory Actions on Biological Pesticides H.R. 872: Reducing Regulatory Burdens Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT CARR | — |
| SARAH THORNTON CASWELL New | — |
| BRENT ALAN DELMONTE | — |
| DANA MAURICE O'BRIEN | — |
Trade (domestic/foreign) TRD
World Trade Organization Special 301 Submissions Russian Issues Livestock Cloning/Product Labeling Intellectual Property International Enforcement TransPacific Partnership Sanitary and Phytosanitary Issues Data and Intellectual Property Protection for Pharmaceuticals Foreign Agricultural Biotechnology Laws and Regulations Agricultural Trade Facilitation Act (Rep. Nunes Discussion Draft) Discussions with EU on Animal Cloning Korea Biotechnology Regulations China Biotechnology Regulations International Biotechnology Agreement APEC Agricultural Biotechnology Discussions Labeling of Genetically Engineered Crops U.S. Government Policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| DAVID EDWARDS | — |
| LILA FEISEE | — |
| JEANNE HAGGERTY | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
| MATTHEW SCHUMAKER | — |
| ROY STANFORD ZWAHLEN New | — |
Agriculture AGR
Biomass Crop Assistance Program (BCAP) Funding H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 USDA/APHIS Agricultural Biotechnology Regulations Efficient Science-Based Review of Biotech Products National Environmental Policy Act Requirements Coexistence of Production Systems EPA Regulations on Agricultural Biotechnology Interior, Environment, and Related Agencies Appropriations Act for FY 2012 EPA Notice on PIP Data Requirements Livestock Cloning/Product Labeling Genetically Engineered (GE) Animals H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE Salmon FDA Approval Labeling Labeling of Genetically-Engineered Crops U.S. Government Policy TransPacific Partnership Sanitary and Phytosanitary Issues Foreign Agricultural Biotechnology Laws and Regulations APEC Agricultural Biotechnology Discussions Agricultural Trade Facilitation Act (Rep. Nunes Discussion Draft) China Biotechnology Regulations Discussions with EU on Animal Cloning International Biotechnology Agreement Korea Biotechnology Regulations Regulatory Actions on Biological Pesticides H.R. 872: Reducing Regulatory Burdens Act of 2011 Agricultural Biotechnology Regulatory Reform and Modernization House Agriculture Subcommittee Hearing (June 2011)
| Lobbyist | Covered position, as disclosed |
|---|---|
| AB BASU New | — |
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
Taxation/Internal Revenue Code TAX
Bio-based Products Tax Credit Election of R&D/AMT Tax Credits in Lieu of Bonus Depreciation Therapeutic Discovery Project Tax Credit Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Extension Biofuels Biofuels Production Tax Credit Modification for Algae-based Biofuels Biofuels Production Tax Credit Extension Investment Tax Credit Options Research & Development Tax Credit Extension H.R. 942: American Research and Competitiveness Act of 2011 Capital Formation Investment Incentives Renewable Chemicals New Production Tax Credit/Revisions to Existing Tax Credits
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| MATT CARR | — |
| SARAH THORNTON CASWELL New | — |
| BRENT ALAN DELMONTE | — |
| ALAN EISENBERG | — |
| ELIZABETH CARTIER ESHAM | — |
| SHELLY MUI-LIPNIK | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW SCHUMAKER | — |
| RINA SINGH New | — |
| TOOSHAR SWAIN | — |
| ANNA KATHERINE WEINSTEIN | — |
Copyright/Patent/Trademark CPT
Patent Reform H.R. 1249: The Leahy-Smith America Invents Act of 2011 S. 23: The Patent Reform Act of 2011 World Trade Organization Special 301 Submissions Russian Issues PTO Administrative Reforms DNA Patenting and Licensing Rep. Wasserman Schultz Amendment to H.R. 1249: The Leahy-Smith America Invents Act of 2011 Intellectual Property International Enforcement TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| LILA FEISEE | — |
| JEANNE HAGGERTY | — |
| DANA MAURICE O'BRIEN | — |
| HANSJORG SAUER | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
| ROY STANFORD ZWAHLEN New | — |
Health Issues HCR
Medicare Prescription Drug Coverage Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Vaccine Access/Financing S. 1094: Combating Autism Reauthorization Act Expansion of 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Medicaid Rebates Dual Eligibles Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review Regulatory Reforms for Innovative Products Prescription Drug User Fee Act (PDUFA) Reauthorization Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 1/H.J. RES 92: Continuing Appropriations Act for FY 2011 H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Independent Payment Advisory Board Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Repeal Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 H.J. RES.48: Department of Defense and Further Additional Continuing Appropriations Act for FY 2011 H.R. 1/H.J. RES.92: Continuing Appropriations Act for FY 2011 Cures Acceleration Network Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biodefense Research, Development and Procurement HHS Countermeasures Review Pandemic and All-Hazards Preparedness Act Reauthorization Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Medicare Policies and Regulation
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| SANDRA DENNIS | — |
| TOM DILENGE | — |
| ALAN EISENBERG | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| LILA FEISEE | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| SHELLY MUI-LIPNIK | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| LAUREL TODD | — |
| ANNA KATHERINE WEINSTEIN | — |
| ROY STANFORD ZWAHLEN New | — |
Small Business SMB
Capital Formation Investment Incentives Sarbanes Oxley Section 404 (b) Exemption Small Business Innovation and Research (SBIR) Program Reauthorization S.493: SBIR/STTR Reauthorization Act of 2011 HR 1425: Creating Jobs Through Small Business Innovation Act of 2011 Therapeutic Discovery Project Tax Credit Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Extension
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| ALAN EISENBERG | — |
| ELIZABETH CARTIER ESHAM | — |
| SHELLY MUI-LIPNIK | — |
| MATTHEW SCHUMAKER | — |
| TOOSHAR SWAIN | — |
| ANNA KATHERINE WEINSTEIN | — |
Medical/Disease Research/Clinical Labs MED
Cures Acceleration Network Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Rare Pediatric & Tropical Disease Drug Development Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 H.J. RES. 48: Department of Defense and Further Additional Continuing Appropriations Act for FY 2011 H.R. 1/H.J. RES.92: Continuing Appropriations Act for FY 2011 Biodefense Research, Development and Procurement HHS Countermeasures Review Pandemic and All-Hazards Preparedness Act Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| ELIZABETH CARTIER ESHAM | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.